Company profile PYXS
After 39 days of this quarter the interest is at 8.0. Based on that we can calculate that during remaining 52 days it will total up to 19.0. Pyxis Oncology expected interest is significantly lower compared to same quarter last year (-85.5%) but higher than previous quarter (+46.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 1 inf% QoQ | 5 400.0% QoQ | 4 -20.0% QoQ |
| 2020 | 3 inf% YoY -25.0% QoQ | 2 100.0% YoY -33.3% QoQ | 2 -60.0% YoY 0.0% QoQ | 2 -50.0% YoY 0.0% QoQ |
| 2021 | 6 100.0% YoY 200.0% QoQ | 5 150.0% YoY -16.7% QoQ | 10 400.0% YoY 100.0% QoQ | 13 550.0% YoY 30.0% QoQ |
| 2022 | 11 83.3% YoY -15.4% QoQ | 7 40.0% YoY -36.4% QoQ | 6 -40.0% YoY -14.3% QoQ | 7 -46.2% YoY 16.7% QoQ |
| 2023 | 131 1090.9% YoY 1771.4% QoQ | 73 942.9% YoY -44.3% QoQ | 18 200.0% YoY -75.3% QoQ | 13 85.7% YoY -27.8% QoQ |
| 2024 | 8 -93.9% YoY -38.5% QoQ | - | - | - |
The average 5 years interest of Pyxis Oncology was 1.25 per week. The last year interest of Pyxis Oncology compared to the last 5 years has changed by 269.6%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 2331.58%.
After 39 days of this quarter the interest is at 9.0. Based on that we can calculate that during remaining 52 days it will total up to 21.0. Pyxis Oncology stock expected interest is significantly lower compared to same quarter last year (-83.2%) but higher than previous quarter (+75.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 0 | 7 inf% QoQ | 9 28.6% QoQ |
| 2020 | 2 inf% YoY -77.8% QoQ | 6 inf% YoY 200.0% QoQ | 6 -14.3% YoY 0.0% QoQ | 4 -55.6% YoY -33.3% QoQ |
| 2021 | 7 250.0% YoY 75.0% QoQ | 5 -16.7% YoY -28.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 7 75.0% YoY inf% QoQ |
| 2022 | 2 -71.4% YoY -71.4% QoQ | 6 20.0% YoY 200.0% QoQ | 4 inf% YoY -33.3% QoQ | 2 -71.4% YoY -50.0% QoQ |
| 2023 | 125 6150.0% YoY 6150.0% QoQ | 77 1183.3% YoY -38.4% QoQ | 16 300.0% YoY -79.2% QoQ | 12 500.0% YoY -25.0% QoQ |
| 2024 | 9 -92.8% YoY -25.0% QoQ | - | - | - |
The average 5 years interest of Pyxis Oncology stock was 1.17 per week. The last year interest of Pyxis Oncology stock compared to the last 5 years has changed by 288.03%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1364.52%.
There is not enough data for Pyxis Oncology clinical trials to provide analysis
There is not enough data for Pyxis Oncology clinical trials to provide correlation calculation
There is not enough data for Pyxis Oncology clinical trials to provide analysis
There is not enough data for Pyxis Oncology antibody therapies to provide analysis
There is not enough data for Pyxis Oncology antibody therapies to provide correlation calculation
There is not enough data for Pyxis Oncology antibody therapies to provide analysis
There is not enough data for Pyxis Oncology cancer treatments to provide analysis
There is not enough data for Pyxis Oncology cancer treatments to provide correlation calculation
There is not enough data for Pyxis Oncology cancer treatments to provide analysis
There is not enough data for Pyx-106 Phase 1 trial to provide analysis
There is not enough data for Pyx-106 Phase 1 trial to provide correlation calculation
There is not enough data for Pyx-106 Phase 1 trial to provide analysis
There is not enough data for Pyx-201 Phase 1 trial to provide analysis
There is not enough data for Pyx-201 Phase 1 trial to provide correlation calculation
There is not enough data for Pyx-201 Phase 1 trial to provide analysis
There is not enough data for Pyxis Oncology headquarters to provide analysis
There is not enough data for Pyxis Oncology headquarters to provide correlation calculation
There is not enough data for Pyxis Oncology headquarters to provide analysis
There is not enough data for Pyxis Oncology contact information to provide analysis
There is not enough data for Pyxis Oncology contact information to provide correlation calculation
There is not enough data for Pyxis Oncology contact information to provide analysis